Schonfeld Strategic Advisors LLC Ocular Therapeutix, Inc Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $71,357 - $139,818	-11,584 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$9.7 - $14.34 $162,145 - $239,707	-16,716 Reduced 59.07%	11,584 $116,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $380,069 - $542,228	28,300 New	28,300 $402,000
Q1 2019 May 15, 2019	SELL	$3.51 - $4.77 $53,162 - $72,246	-15,146 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.87 - $7.11 $58,615 - $107,688	15,146 New	15,146 $60,000

151

136M

86.4K

263K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.